Journals / Androloji Bülteni / 2018 / Cilt: 20 - Sayı: 4

Female sexual function disorders: Updating 2018

Kadın cinsel fonksiyon bozuklukları: 2018 güncelleme

Pages
133–137
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Early detection of complaints will ensure the physical, emotional, and well-being of women and increase their quality of life.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Female sexual dysfunction (FSD); sexual dysfunction, orgasm, arousal, and sexual pain or a combination of all or some of the problems of psychosexual disorders.
📊
Key Findings & Data:While KCD has been identified as five in the past, the DSM-5 has been simplified and grouped under three headings.
💡
Conclusion & Impact:Early detection of complaints will ensure the physical, emotional, and well-being of women and increase their quality of life.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Female sexual dysfunction (FSD); sexual dysfunction, orgasm, arousal, and sexual pain or a combination of all or some of the problems of psychosexual disorders. While KCD has been identified as five in the past, the DSM-5 has been simplified and grouped under three headings. Female hypoactive sexual desire and arousal dysfunction is combined into a single topic as female sexual arousal / arousal disorder. Previously separated dyspareunia and vaginismus are called genitopelvic pain/ penetration disorders. Female orgasmic disorder has remained a category and has not changed. Early detection of complaints will ensure the physical, emotional, and well-being of women and increase their quality of life.

Özet

Kadın cinsel disfonksiyonu (KCD); cinsel istek bozukluğu, orgazm, uyarılma ve cinsel ağrı gibi problemlerin birkaçını ya da tamamını bir arada bulunduran, psikoseksüel hastalıklar topluluğudur. Önceden beş tane olarak tanımlanan KCD, DSM-5’te sadeleştirilmiş ve üç ana başlık altında toplanmıştır. Kadın hipoaktif cinsel istek ve uyarılma disfonksiyonu, kadın cinsel ilgi/uyarılma bozukluğu olarak tek bir başlıkta birleştirilmiştir. Önceden ayrı olan disparoni ve vajinismus, genitopelvik ağrı / penetrasyon bozukluğu olarak adlandırılmıştır. Kadın orgazm bozukluğu bir kategori olarak kalmış ve değiştirilmemiştir. Şikâyetlerin erken dönemde saptanması, kadınların fiziksel, emosyonel, sağlığının korunmasını ve yaşam kalitesinin artmasını sağlayacaktır.

🔖

Cite This Article

ÖZCAN, H., BEJİ, N. K. (2018). Female sexual function disorders: Updating 2018. Androloji Bülteni, Cilt: 20 - Sayı: 4, 133–137. https://ajindex.com/articles/146147

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Buster JE. Managing female sexual dysfunction. Fertil Steril 2013;100:905–15. [CrossRef] Moreira ED, Glasser DB, Nicolosi A, Duarte FG, Gingell C; GSSAB Investigators’ Group. Sexual problems and help-seeking behaviour in adults in the United Kingdom and continental Europe. BJU Int 2008;101:1005–11. [CrossRef] Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 2008;112:970–8. [CrossRef] Hassanin IM, Helmy YA, Fathalla MM, Shahin AY. Prevalence and charactetistics of female sexual dysfunction in a sample of women from Upper Egypt. Int J Gynaecol Obstet 2010;108:219–23. [CrossRef] Öksüz E, Malhan S. Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol 2006;175:654–8. [CrossRef] Ege E, Akın B, Yaralı Arslan S, Bilgili N. Sağlıklı kadınlarda cinsel fonksiyon bozukluğu ve risk faktörleri. TUBAV Bilim Dergisi 2010;3:137–44.
  2. Akbulut MF, Üçpınar MB, Gürbüz ZG. Kadınlarda cinsel fonksiyon bozukluklarının sınıflaması ve tedavisi. Türkiye Klinikleri J Urology - Special Topics 2015;8:10–5.
  3. Nappi RE, Cucinella L, Martella S, Rossi M, Tiranini L, Martini E. Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL). Maturitas 2016;94:87–91. [CrossRef] Gomaa AA, Aziz NM, Thabet RH, Fouly HA, Altellawly SH, Gomaa GA. A pilot study of a topical intervention for treatment of female sexual dysfunction. J Clin Psychopharmacol 2018;38:60–7. [CrossRef] Elnashar AM, İbrahim ME, El-Desoky MM, Ali OM, Hassan MESM. Female sexual dysfunction in lower Egypt. BJOG 2007;114:201–6. [CrossRef] ISSWSH/NAMS Consensus Committee. ISSWSH position statement. J Sex Med 2014;11:1109. [CrossRef] Latif EZ, Diamond MP. Arriving at the diagnosis of female sexual dysfunction. Fertil Steril 2013;100:898–904. [CrossRef] Stephenson KR, Toorabally N, Lyons L, Meston C. Further validation of the Female Sexual Function Index: Specificity and associations with clinical interview Data. J Sex Marital Ther 2016;42:448–61. [CrossRef] Krakowsky Y, Grober ED. A practical guide to female sexual dysfunction: An evidence-based review for physicians in Canada. Can Urol Assoc J 2018;12:211–6. [CrossRef] Malmborg A, Persson E, Brynhildsen J, Hammar M. Hormonal contraception and sexual desire: A questionnaire-based study of young Swedish women. Eur J Contracept Reprod Health Care 2016;21:158–67. [CrossRef] Cortelazzi D, Marconi A, Guazzi M, Cristina M, Zecchini B, Veronelli